| 000 | 01675 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517114808.0 | ||
| 264 | 0 | _c20170925 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1555-8576 | ||
| 024 | 7 |
_a10.1080/15384047.2016.1235664 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeck, Alexander | |
| 245 | 0 | 0 |
_aConnectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastoma. _h[electronic resource] |
| 260 |
_bCancer biology & therapy _c11 2016 |
||
| 300 |
_a1168-1176 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 |
_aHepatoblastoma _xdrug therapy |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aHistone Deacetylases _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTranscriptome |
| 700 | 1 | _aEberherr, Corinna | |
| 700 | 1 | _aHagemann, Michaela | |
| 700 | 1 | _aCairo, Stefano | |
| 700 | 1 | _aHäberle, Beate | |
| 700 | 1 | _aVokuhl, Christian | |
| 700 | 1 | _avon Schweinitz, Dietrich | |
| 700 | 1 | _aKappler, Roland | |
| 773 | 0 |
_tCancer biology & therapy _gvol. 17 _gno. 11 _gp. 1168-1176 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/15384047.2016.1235664 _zAvailable from publisher's website |
| 999 |
_c26425394 _d26425394 |
||